Regulation of lipogenesis by glucocorticoids and insulin in human adipose tissue

Patients with glucocorticoid (GC) excess, Cushing's syndrome, develop a classic phenotype characterized by central obesity and insulin resistance. GCs are known to increase the release of fatty acids from adipose, by stimulating lipolysis, however, the impact of GCs on the processes that regula...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Gathercole, L, Morgan, SA, Bujalska, I, Hauton, D, Stewart, P, Tomlinson, J
Fformat: Journal article
Iaith:English
Cyhoeddwyd: Public Library of Science 2011
_version_ 1826298366831624192
author Gathercole, L
Morgan, SA
Bujalska, I
Hauton, D
Stewart, P
Tomlinson, J
author_facet Gathercole, L
Morgan, SA
Bujalska, I
Hauton, D
Stewart, P
Tomlinson, J
author_sort Gathercole, L
collection OXFORD
description Patients with glucocorticoid (GC) excess, Cushing's syndrome, develop a classic phenotype characterized by central obesity and insulin resistance. GCs are known to increase the release of fatty acids from adipose, by stimulating lipolysis, however, the impact of GCs on the processes that regulate lipid accumulation has not been explored. Intracellular levels of active GC are dependent upon the activity of 11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) and we have hypothesized that 11β-HSD1 activity can regulate lipid homeostasis in human adipose tissue (Chub-S7 cell line and primary cultures of human subcutaneous (sc) and omental (om) adipocytes. Across adipocyte differentiation, lipogenesis increased whilst β-oxidation decreased. GC treatment decreased lipogenesis but did not alter rates of β-oxidation in Chub-S7 cells, whilst insulin increased lipogenesis in all adipocyte cell models. Low dose Dexamethasone pre-treatment (5 nM) of Chub-S7 cells augmented the ability of insulin to stimulate lipogenesis and there was no evidence of adipose tissue insulin resistance in primary sc cells. Both cortisol and cortisone decreased lipogenesis; selective 11β-HSD1 inhibition completely abolished cortisone-mediated repression of lipogenesis. GCs have potent actions upon lipid homeostasis and these effects are dependent upon interactions with insulin. These in vitro data suggest that manipulation of GC availability through selective 11β-HSD1 inhibition modifies lipid homeostasis in human adipocytes.
first_indexed 2024-03-07T04:45:45Z
format Journal article
id oxford-uuid:d331cbb6-c2f8-4e10-8b96-2e1ba39f16f0
institution University of Oxford
language English
last_indexed 2024-03-07T04:45:45Z
publishDate 2011
publisher Public Library of Science
record_format dspace
spelling oxford-uuid:d331cbb6-c2f8-4e10-8b96-2e1ba39f16f02022-03-27T08:09:33ZRegulation of lipogenesis by glucocorticoids and insulin in human adipose tissueJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:d331cbb6-c2f8-4e10-8b96-2e1ba39f16f0EnglishSymplectic Elements at OxfordPublic Library of Science2011Gathercole, LMorgan, SABujalska, IHauton, DStewart, PTomlinson, JPatients with glucocorticoid (GC) excess, Cushing's syndrome, develop a classic phenotype characterized by central obesity and insulin resistance. GCs are known to increase the release of fatty acids from adipose, by stimulating lipolysis, however, the impact of GCs on the processes that regulate lipid accumulation has not been explored. Intracellular levels of active GC are dependent upon the activity of 11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) and we have hypothesized that 11β-HSD1 activity can regulate lipid homeostasis in human adipose tissue (Chub-S7 cell line and primary cultures of human subcutaneous (sc) and omental (om) adipocytes. Across adipocyte differentiation, lipogenesis increased whilst β-oxidation decreased. GC treatment decreased lipogenesis but did not alter rates of β-oxidation in Chub-S7 cells, whilst insulin increased lipogenesis in all adipocyte cell models. Low dose Dexamethasone pre-treatment (5 nM) of Chub-S7 cells augmented the ability of insulin to stimulate lipogenesis and there was no evidence of adipose tissue insulin resistance in primary sc cells. Both cortisol and cortisone decreased lipogenesis; selective 11β-HSD1 inhibition completely abolished cortisone-mediated repression of lipogenesis. GCs have potent actions upon lipid homeostasis and these effects are dependent upon interactions with insulin. These in vitro data suggest that manipulation of GC availability through selective 11β-HSD1 inhibition modifies lipid homeostasis in human adipocytes.
spellingShingle Gathercole, L
Morgan, SA
Bujalska, I
Hauton, D
Stewart, P
Tomlinson, J
Regulation of lipogenesis by glucocorticoids and insulin in human adipose tissue
title Regulation of lipogenesis by glucocorticoids and insulin in human adipose tissue
title_full Regulation of lipogenesis by glucocorticoids and insulin in human adipose tissue
title_fullStr Regulation of lipogenesis by glucocorticoids and insulin in human adipose tissue
title_full_unstemmed Regulation of lipogenesis by glucocorticoids and insulin in human adipose tissue
title_short Regulation of lipogenesis by glucocorticoids and insulin in human adipose tissue
title_sort regulation of lipogenesis by glucocorticoids and insulin in human adipose tissue
work_keys_str_mv AT gathercolel regulationoflipogenesisbyglucocorticoidsandinsulininhumanadiposetissue
AT morgansa regulationoflipogenesisbyglucocorticoidsandinsulininhumanadiposetissue
AT bujalskai regulationoflipogenesisbyglucocorticoidsandinsulininhumanadiposetissue
AT hautond regulationoflipogenesisbyglucocorticoidsandinsulininhumanadiposetissue
AT stewartp regulationoflipogenesisbyglucocorticoidsandinsulininhumanadiposetissue
AT tomlinsonj regulationoflipogenesisbyglucocorticoidsandinsulininhumanadiposetissue